BRAINSWAY LTD-ADR (BWAY)
US10501L1061 - ADR
Overall BWAY gets a fundamental rating of 5 out of 10. We evaluated BWAY against 187 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for BWAY as it has an excellent financial health rating, but there are worries on the profitability. BWAY is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
In the past year BWAY was profitable.
BWAY had a positive operating cash flow in the past year.
BWAY had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BWAY reported negative operating cash flow in multiple years.
1.2 Ratios
BWAY has a Return On Assets of -6.66%. This is in the better half of the industry: BWAY outperforms 61.50% of its industry peers.
With a decent Return On Equity value of -10.08%, BWAY is doing good in the industry, outperforming 64.17% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.66% | ||
| ROE | -10.08% | ||
| ROIC | N/A |
ROA(3y)-11.97%
ROA(5y)-15.68%
ROE(3y)-16.92%
ROE(5y)-24.18%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 73.83%, BWAY belongs to the top of the industry, outperforming 84.49% of the companies in the same industry.
In the last couple of years the Gross Margin of BWAY has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for BWAY so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 73.83% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.4%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
BWAY does not have a ROIC to compare to the WACC, probably because it is not profitable.
BWAY has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BWAY has been increased compared to 5 years ago.
Compared to 1 year ago, BWAY has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.89 indicates that BWAY is not in any danger for bankruptcy at the moment.
BWAY has a Altman-Z score of 3.89. This is in the better half of the industry: BWAY outperforms 71.66% of its industry peers.
BWAY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.89 |
ROIC/WACCN/A
WACC9.45%
2.3 Liquidity
BWAY has a Current Ratio of 5.68. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 5.68, BWAY is doing good in the industry, outperforming 79.68% of the companies in the same industry.
BWAY has a Quick Ratio of 5.30. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
BWAY has a Quick ratio of 5.30. This is amongst the best in the industry. BWAY outperforms 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.68 | ||
| Quick Ratio | 5.3 |
3. Growth
3.1 Past
BWAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 114.84%, which is quite impressive.
Looking at the last year, BWAY shows a quite strong growth in Revenue. The Revenue has grown by 16.94% in the last year.
BWAY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.15% yearly.
EPS 1Y (TTM)114.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%277.3%
Revenue 1Y (TTM)16.94%
Revenue growth 3Y12.95%
Revenue growth 5Y14.15%
Sales Q2Q%25.47%
3.2 Future
BWAY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 60.77% yearly.
Based on estimates for the next years, BWAY will show a very strong growth in Revenue. The Revenue will grow by 24.11% on average per year.
EPS Next Y118.31%
EPS Next 2Y72.19%
EPS Next 3Y60.77%
EPS Next 5YN/A
Revenue Next Year25.74%
Revenue Next 2Y22.97%
Revenue Next 3Y24.11%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
BWAY is valuated quite expensively with a Price/Earnings ratio of 35.96.
Based on the Price/Earnings ratio, BWAY is valued a bit cheaper than the industry average as 70.59% of the companies are valued more expensively.
BWAY's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.54.
The Price/Forward Earnings ratio is 10.54, which indicates a very decent valuation of BWAY.
Based on the Price/Forward Earnings ratio, BWAY is valued cheaper than 96.26% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BWAY to the average of the S&P500 Index (23.99), we can say BWAY is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.96 | ||
| Fwd PE | 10.54 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
BWAY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BWAY's earnings are expected to grow with 60.77% in the coming years.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y72.19%
EPS Next 3Y60.77%
5. Dividend
5.1 Amount
BWAY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BRAINSWAY LTD-ADR
NASDAQ:BWAY (12/24/2024, 7:59:32 PM)
9.35
+0.2 (+2.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners17.08%
Inst Owner Change-8.23%
Ins Owners19.81%
Ins Owner ChangeN/A
Market Cap175.90M
Analysts85.71
Price Target0.08 (-99.14%)
Short Float %0.08%
Short Ratio0.28
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)89.14%
Min EPS beat(2)78.27%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)57.97%
Min EPS beat(4)15.49%
Max EPS beat(4)100%
EPS beat(8)4
Avg EPS beat(8)-7.06%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.71%
Min Revenue beat(2)1.95%
Max Revenue beat(2)7.47%
Revenue beat(4)3
Avg Revenue beat(4)-14.15%
Min Revenue beat(4)-73.38%
Max Revenue beat(4)7.47%
Revenue beat(8)3
Avg Revenue beat(8)-44.03%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.16%
PT rev (3m)9.32%
EPS NQ rev (1m)11.35%
EPS NQ rev (3m)11.35%
EPS NY rev (1m)-11.35%
EPS NY rev (3m)-45.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.96 | ||
| Fwd PE | 10.54 | ||
| P/S | 5.53 | ||
| P/FCF | N/A | ||
| P/OCF | 137 | ||
| P/B | 4.23 | ||
| P/tB | 4.23 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.26
EY2.78%
EPS(NY)0.89
Fwd EY9.48%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)0.07
OCFY0.73%
SpS1.69
BVpS2.21
TBVpS2.21
PEG (NY)0.3
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.66% | ||
| ROE | -10.08% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 73.83% | ||
| FCFM | N/A |
ROA(3y)-11.97%
ROA(5y)-15.68%
ROE(3y)-16.92%
ROE(5y)-24.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.4%
GM growth 5Y-1.11%
F-Score6
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 178.53% | ||
| Cap/Sales | 7.51% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.68 | ||
| Quick Ratio | 5.3 | ||
| Altman-Z | 3.89 |
F-Score6
WACC9.45%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%277.3%
EPS Next Y118.31%
EPS Next 2Y72.19%
EPS Next 3Y60.77%
EPS Next 5YN/A
Revenue 1Y (TTM)16.94%
Revenue growth 3Y12.95%
Revenue growth 5Y14.15%
Sales Q2Q%25.47%
Revenue Next Year25.74%
Revenue Next 2Y22.97%
Revenue Next 3Y24.11%
Revenue Next 5YN/A
EBIT growth 1Y60.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year131.03%
EBIT Next 3Y39.92%
EBIT Next 5YN/A
FCF growth 1Y88.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y113.16%
OCF growth 3YN/A
OCF growth 5YN/A